We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+9.06%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.6B
AUM Growth
+$2.6B
(+22%)
Cap. Flow
+$859M
Cap. Flow
% of AUM
5.88%
Top 10 Holdings %
Top 10 Hldgs %
21.92%
Holding
958
New
131
Increased
364
Reduced
334
Closed
74
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$135M |
| 2 |
Royal Bank of Canada
RY
|
+$120M |
| 3 |
Agilent Technologies
A
|
+$72.5M |
| 4 |
UnitedHealth
UNH
|
+$71.5M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$64.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$90.3M |
| 2 |
Amgen
AMGN
|
+$88.7M |
| 3 |
Allstate
ALL
|
+$52.2M |
| 4 |
Union Pacific
UNP
|
+$47.1M |
| 5 |
Bio-Rad Laboratories Class A
BIO
|
+$44.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 33.42% |
| 2 | Technology | 23.2% |
| 3 | Consumer Discretionary | 9.14% |
| 4 | Financials | 8.63% |
| 5 | Communication Services | 7.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Nike
NKE
$61.9B
| $99.8M | 0.68% |
646,128
+116,404
| +22% | +$15.7M |
|
27
Qualcomm
QCOM
$176B
| $96.1M | 0.66% |
672,163
-52,416
| -7% | -$7.09M |
|
28
Tesla
TSLA
$1.24T
| $95.7M | 0.66% |
422,268
-42,645
| -9% | -$9.26M |
|
29
Biogen
BIIB
$29.9B
| $95.2M | 0.65% |
275,040
-115,830
| -30% | -$35.1M |
|
30
TSMC
TSM
$2.09T
| $94.8M | 0.65% |
788,987
-248,787
| -24% | -$29.1M |
|
31
Waste Management
WM
$95.9B
| $93.4M | 0.64% |
666,286
-26,237
| -4% | -$3.63M |
|
32
Illumina
ILMN
$29.4B
| $92.9M | 0.64% |
201,781
-41,684
| -17% | -$16.8M |
|
|
ALXN
33
DELISTED
Alexion Pharmaceuticals
ALXN
| $92.5M | 0.63% |
503,510
-106,772
| -17% | -$18.3M |
|
34
Applied Materials
AMAT
$426B
| $91.4M | 0.63% |
641,727
+66,850
| +12% | +$8.97M |
|
35
Salesforce
CRM
$134B
| $91.3M | 0.62% |
373,743
+104,666
| +39% | +$24.1M |
|
|
36
Agilent Technologies
A
$39.1B
| $91.1M | 0.62% |
616,128
+531,392
| +627% | +$72.5M |
|
37
Walt Disney
DIS
$165B
| $88.2M | 0.6% |
501,785
-49,714
| -9% | -$8.94M |
|
38
Charles River Laboratories
CRL
$10.9B
| $88.1M | 0.6% |
238,147
+167,967
| +239% | +$56.1M |
|
39
Bank of America
BAC
$435B
| $88.1M | 0.6% |
2,135,939
+1,185,565
| +125% | +$48.6M |
|
40
Advanced Micro Devices
AMD
$851B
| $80.8M | 0.55% |
860,261
+504,649
| +142% | +$40.8M |
|
41
Palo Alto Networks
PANW
$264B
| $78.9M | 0.54% |
1,275,036
-12,588
| -1% | -$746K |
|
42
Home Depot
HD
$332B
| $77.1M | 0.53% |
241,722
+18,679
| +8% | +$5.94M |
|
43
Abbott
ABT
$180B
| $76.6M | 0.52% |
660,544
+192,623
| +41% | +$22.5M |
|
44
Moderna
MRNA
$21.5B
| $72.1M | 0.49% |
307,014
-89,153
| -23% | -$15.9M |
|
45
Air Products & Chemicals
APD
$66.3B
| $71.6M | 0.49% |
248,992
+62,114
| +33% | +$18.2M |
|
|
XLRN
46
DELISTED
Acceleron Pharma
XLRN
| $69.9M | 0.48% |
557,055
+121
| +0% | +$15.3K |
|
47
Starbucks
SBUX
$118B
| $65.2M | 0.45% |
583,444
-49,784
| -8% | -$5.63M |
|
48
Rockwell Automation
ROK
$51.4B
| $65.1M | 0.45% |
227,723
+42,580
| +23% | +$11.5M |
|
49
Autodesk
ADSK
$44.3B
| $64.5M | 0.44% |
221,079
-38,011
| -15% | -$10.8M |
|
50
Emerson Electric
EMR
$82.9B
| $63.8M | 0.44% |
663,093
-9,083
| -1% | -$854K |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q2 2021 Portfolio in Review
As of Q2 2021, Candriam SCA held 958 positions worth $14.6B, up 22% from $12B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Candriam SCA deployed $859M of net new capital in Q2 2021, opening 131 new positions and adding to 364 existing holdings. Its largest new stake was SailPoint Technologies Holdings, Inc. Common Stock: 738,233 shares worth $37.7M.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 34% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $90.3M trimmed.
- Candriam SCA's largest Q2 2021 buy was SailPoint Technologies Holdings, Inc. Common Stock: 738,233 shares worth $37.7M.
- Candriam SCA added most to Microsoft in Q2 2021, an estimated $135M increase.
- Candriam SCA's biggest Q2 2021 reduction was Bristol-Myers Squibb, cutting an estimated $90.3M.
- Candriam SCA fully exited Tenable Holdings in Q2 2021, selling an estimated $31.6M.
- Candriam SCA's ten largest holdings make up 22% of its $14.6B portfolio in Q2 2021.
- Candriam SCA opened 131 new positions and closed 74 in Q2 2021.
- Candriam SCA's portfolio value rose 22% quarter-over-quarter to $14.6B.
Based on Candriam SCA's 13F filing for Q2 2021, filed 20 Jul 2021.